Connection
Raphael Nemenoff to Complement Inactivating Agents
This is a "connection" page, showing publications Raphael Nemenoff has written about Complement Inactivating Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.322 |
|
|
|
-
Gadwa J, Bickett TE, Darragh LB, Knitz MW, Bhatia S, Piper M, Van Court B, Bhuvane S, Nguyen D, Nangia V, Kleczko EK, Nemenoff RA, Karam SD. Complement C3a and C5a receptor blockade modulates regulatory T cell conversion in head and neck cancer. J Immunother Cancer. 2021 03; 9(3).
Score: 0.171
-
Kleczko EK, Kwak JW, Schenk EL, Nemenoff RA. Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer. Front Immunol. 2019; 10:954.
Score: 0.151